Biogen earnings, Revenue beat in Q3


Investing.com – Biogen (NASDAQ:) reported on Tuesday third quarter that beat analysts’ forecasts and revenue that topped expectations.

Biogen announced earnings per share of $4.77 on revenue of $2.51. Analysts polled by Investing.com anticipated EPS of $4.14 on revenue of $2.47B.

Biogen shares are down 13.16% from the beginning of the year and are trading at $274.62 , down-from-52-week-high.

Biogen follows other major Healthcare sector earnings this month

Biogen’s report follows an earnings beat by UnitedHealth on Friday, October 14, 2022, who reported EPS of $5.79 on revenue of $80.9B, compared to forecasts EPS of $5.43 on revenue of $80.52B.

J&J had beat expectations on Tuesday, October 18, 2022 with third quarter EPS of $2.55 on revenue of $23.79B, compared to forecast for EPS of $2.52 on revenue of $23.46B.

Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar



Source link

Leave a Comment